DASH
Repository logo
Communities & Collections
Browse DASH
DASH Stories
Statistics
  1. Home
  2. Harvard Division of Continuing Education
  3. DCE Theses and Dissertations
  4. Utilization of High Throughput CRISPR Knockout Technologies to Identify Cellular Genes Involved in Human Papillomavirus Degradation of p53

Utilization of High Throughput CRISPR Knockout Technologies to Identify Cellular Genes Involved in Human Papillomavirus Degradation of p53

Open/View files
Final_Thesis_EML.pdf (1.84 MB)
Date
May 10, 2022
Author(s)
Lilienthal, Erin Macy
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Lilienthal, Erin Macy. 2022. Utilization of High Throughput CRISPR Knockout Technologies to Identify Cellular Genes Involved in Human Papillomavirus Degradation of p53. Master's thesis, Harvard University Division of Continuing Education.
Abstract
High-risk human papillomaviruses (hrHPVs) are the causative agents for most cases of cervical cancer; they have also been linked to other anogenital cancers as well as head and neck cancers. Vaccines against HPV were introduced in the mid-2000s, and while they are effective at preventing new HPV infection, they do nothing to help the tens of millions of people currently infected with hrHPV and are not readily available in certain parts of the world. High-risk HPVs encode two oncoproteins – E6 and E7 – which target the cellular tumor suppressors p53 and Rb respectively. E6 works with other cellular proteins to ubiquitylate the cellular tumor suppressor p53, effectively marking it for degradation by the proteasome. Inhibiting E6-mediated ubiquitylation of p53 in HPV-positive cervical cancer cells leads to p53 stabilization. Since HPV-positive cancers express wild-type p53, restoration of p53 triggers cells to undergo apoptosis. To address the need for novel therapeutics to treat HPV-induced cancers, we designed a functional genomics screen to identify cellular genes that are involved in hrHPV E6-mediated degradation of p53 in cervical cancer cells. Utilizing clustered regulatory interspaced short palindromic repeats (CRISPR)/ Cas9 technology, we screened over 8,000 cellular genes to identify those that, when knocked out, stabilized p53. This screen led to the identification of cellular targets, both previously identified and novel, that contribute to p53 degradation in HPV-positive cells. We are hopeful these findings will provide potential therapeutic targets for HPV-induced cancers.
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
URI
https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37371530
Subjects

CRISPR

high throughput scree...

HPV

p53

Biology

Collection
DCE Theses and Dissertations
Metrics
Repository logo
  • CONTACT US
  • OSRDS
  • ABOUT DASH
  • DEPOSITING TO DASH
  • TERMS OF USE
  • REQUEST A WAIVER
  • TAKE DOWN POLICY
  • NAME CHANGE POLICY
  • HARVARD OA POLICIES
  • DASH SUBMITTER AGREEMENT
  • Accessibility
  • Privacy
Creative Commons License BY
Creative Commons Attribution 4.0 International License

Except where otherwise noted, this work is subject to a Creative Commons Attribution 4.0 International License,
which allows anyone to share and adapt our material as long as proper attribution is given.
For details and exceptions, see the Harvard Library Copyright Policy
©2024 Presidents and Fellows of Harvard College.